Friday, August 14, 2026

Back to today

From X

Entravision Q2 Notes

Entravision’s ATS revenue rose 230% to $182.8 million in Q2, but shares fell from above $14 to about $8 after management forecast…

CUE · short

Cue Biopharma

Cue Biopharma faces a deteriorating balance sheet, recurring operating losses, ATM dilution and PIPE-investor selling pressure.

The Strategic Value of eDreams

EDreams’ Prime travel subscription model makes the €3.6 billion European OTA a potential Uber, Airbnb or Amazon acquisition target.

Publications we follow

Every publication on this site, hand-picked.

109 publications

Newsletters 92

X accounts we follow

Every account on this site, hand-picked.

74 accounts

Investor letters we follow

189 firms

Sectors

Ordered by how often our editor reaches for them.